News
In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...
5d
News-Medical.Net on MSNADA2 regulates inflammation through lysosomal and extracellular mechanismsAdenosine deaminase 2 (ADA2) plays a critical role in immune regulation, particularly in monocyte differentiation and ...
5h
News Medical on MSNPathogenic mechanisms of Fusobacterium nucleatum in colorectal cancer and emerging therapiesIn recent years, the regulatory role of the gut microbiota in the initiation and progression of colorectal cancer (CRC) has attracted growing attention. Among the key microbial contributors, ...
4d
AZoNano on MSNNovel Polyphenol-Metal Nanocarrier for Antibody DeliveryA breakthrough in cancer therapy: metal-phenolic nanocarriers deliver antibodies directly to cancer cells, improving ...
Researchers create nanomachines using metal and polyphenols, which enhance targeted intracellular delivery of antibodies for ...
Hosted on MSN7mon
Intracellular checkpoints for natural killer cell cancer ... - MSNTargeting intracellular checkpoints could be combined with other strategies, such as tumor sensors, immune checkpoint blockade, and synthetic gene circuits, to enhance NK cell immunotherapy.
In a significant step towards improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...
Targeting intracellular checkpoints could be combined with other strategies, such as tumor sensors, immune checkpoint blockade, and synthetic gene circuits, to enhance NK cell immunotherapy.
Researchers explore targeting intracellular tau aggregates for destruction, offering potential therapeutic advancements in neurodegenerative diseases like Alzheimer's.
Inhibiting promising intracellular checkpoint targets like CISH have dramatic anti-cancer potential, but have traditionally been thought to be undruggable," said Emil Lou, M.D., Ph.D., Principal ...
Halda Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating HLD-0915 in Metastatic Castration-Resistant Prostate Cancer ...
Parabilis’s ERG degrader overcomes this challenge by using the company’s proprietary Helicon peptide technology, which enables intracellular targeting of “flat” protein surfaces.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results